Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology
Agilex Biolabs Pty Ltd runs a Biotechnology operation from Thebarton, South Australia. It is privately held, and its site is agilexbiolabs.com. It holds two addresses on record, all in Australia. Headcount on record is 164. Its work is tagged clinical research, vaccines and clinical trials. One Australian registration (ABN) is a confirmed match. The record links ten similar brands, most of them in Biotechnology Research.
ABN41630526699
| AGILEX BIOLABS PTY LTD | ABN 41630526699 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Agilex Biolabs is Australia’s regulated bioanalytical and toxicology CRO offering both large and small molecule development with extensive cell & gene therapy capabilities and expertise. For over 25 years, we are recognised for our scale and proven track record for large and small molecule bioanalysis, including quality method development, method validation and sample analysis services.
Our world-class immunoassay and immunobiology laboratories feature state-of-the-art equipment, including Gyrolab xPlore, MSD Quickplex 120, Luminex Magpix, BD FACSymphony A3 flow cytometer and the digital droplet quantitative real-time analysis for RNA, siRNA, and miRNA clinical trials, including vaccines and gene therapy trials. Furthermore, Agilex Biolabs has ISO/IEC17025 accreditation and OECD GLP recognition with NATA to ensure the highest quality standards are met for seamless end to end testing for pre-clinical to clinical analysis.
Agilex Biolabs also offers a range of toxicology services to support preclinical through to early/late-phase clinical programs through TetraQ, an established GLP facility located in Brisbane, Australia. These services include exploratory toxicology and pharmacokinetics studies, and GLP toxicology services. We have expertise with all types of molecules, laboratory species, routes of administration, and non-clinical studies.
Being at the forefront of regulated bioanalysis, Agilex has invested heavily in world-class customised equipment and is continuing to push the boundaries by investment in new infrastructure, and identification of new ways to automate and streamline data acquisition through to reporting to support scientific and regulatory excellence and maintain its position as the leading bioanalytical laboratory within the Asia Pacific Region.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One South Australia entity on the ABR: AGILEX BIOLABS PTY LTD (ABN 41 630 526 699), high confidence.
164 counted staff profiles at January 2026, inside the self-reported 51–200 band.
Two addresses on record, Australia only. Primary: 31 Dalgleish St, Thebarton, South Australia 5031.
None linked to this brand.
12 tags on the brand's own list, among them clinical research, vaccines and clinical trials.
45 profiles list Agilex Biolabs Pty Ltd as a peer — 99th percentile in Biotechnology. It lists ten peers of its own. BioCina and 360biolabs, a BioAgilytix company list it back.